Back to Journals » Therapeutics and Clinical Risk Management » Volume 13
Original Research
Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,887 | Dovepress* | 10,070+ | 1,567 | 11,637 | |
PubMed Central* | 1,817 | 492 | 2,309 | ||
Totals | 11,887 | 2,059 | 13,946 | ||
*Since 3 August 2017 |
View citations on PubMed Central and Google Scholar